TECX Q3 2022 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$336,000

Operating Income

-$23M

Net Income

-$23M

EPS (Diluted)

$-6.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$129M

Total Liabilities

$31M

Stockholders' Equity

$98M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$336,000	-$374,000	+10.2%
Operating Income	-$23M	-$33M	+29.5%
Net Income	-$23M	-$33M	+29.6%